ED-Finanzas

No es posible guardar favoritos sin iniciar sesión.

Usá Login / Registrar en el header (usuario + contraseña).

FDMT

4D Molecular Therapeutics Inc · NASD

Healthcare · Biotechnology · USA · Small

14.55
+2.36 (+19.32%)
Aug 17 3:59 PM ET

4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine create a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.

Chart

Lightweight Charts · Yahoo Finance

Date Headline URL From
Aug-17-26 07:51PM OCUL, FDMT Stock Clock Best Day In Weeks After EyePoints Trial Setback Heres Why link (Stocktwits)
Aug-14-26 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Aug-13-26 04:05PM 4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones link (GlobeNewswire)
Jul-31-26 09:46AM Roblox downgraded, Quanta Services upgraded: Wall Street's top analyst calls link (The Fly)
Jul-29-26 03:22PM 10 Stock Picks to Celebrate 45 Years of Schaeffer's link (Schaeffer's Research)
Jul-18-26 03:15PM 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population link (GlobeNewswire)
Jul-17-26 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Jun-30-26 04:05PM 4DMT Announces Presentation at 44th Annual Scientific Meeting of the American Society of Retina Specialists link (GlobeNewswire)
Jun-29-26 08:00AM 4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital link (GlobeNewswire)
Jun-29-26 08:00AM 4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD link (GlobeNewswire)
Jun-12-26 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
May-27-26 08:00AM 4DMT to Participate in Upcoming Investor Conferences link (GlobeNewswire)
May-15-26 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
May-07-26 04:05PM 4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones link (GlobeNewswire)
May-04-26 08:00AM 4DMT to Participate in Upcoming Investor Conferences link (GlobeNewswire)
Apr-17-26 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Mar-18-26 04:05PM 4DMT Reports Full Year 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones link (GlobeNewswire)
Mar-16-26 08:00AM 4DMT to Participate in Upcoming Investor Meetings link (GlobeNewswire)
Feb-28-26 02:21AM Where is 4D Molecular Therapeutics (FDMT) Headed According to the Street? link (Insider Monkey)
Feb-19-26 08:00AM 4DMT to Participate in Upcoming Investor Conferences link (GlobeNewswire)
Feb-13-26 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Feb-09-26 08:00AM 4DMT Completes Enrollment for 4FRONT-1 Phase 3 Clinical Trial of 4D-150 in Wet AMD link (GlobeNewswire)
Feb-02-26 09:53AM Barclays Flags M&A Tailwinds and Pricing Relief as Upside Catalysts for 4D Molecular Therapeutics, Inc. (FDMT) link (Insider Monkey)
Jan-17-26 08:00AM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Jan-07-26 08:00AM 4DMT Provides Company Update and Anticipated Development Milestones for 2026 link (GlobeNewswire)
Dec-27-25 07:43AM Why Everyone Is Watching 4D Molecular Therapeutics, Inc. (FDMT) Closely link (Insider Monkey)
Dec-17-25 07:00AM 4DMT Announces Positive Interim Clinical Data from 4D-710 AEROW Phase 1 Clinical Trial in Cystic Fibrosis Lung Disease link (GlobeNewswire)
Dec-12-25 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Dec-08-25 08:00AM 4DMT to Present at the 44th Annual J.P. Morgan Healthcare Conference link (GlobeNewswire)
Nov-20-25 08:00AM 4DMT to Participate in 8th Annual Evercore Healthcare Conference link (GlobeNewswire)
Nov-17-25 06:00AM 4DMT Appoints Kristian Humer as Chief Financial Officer link (GlobeNewswire)
Nov-14-25 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Nov-10-25 09:15AM 4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates link (Zacks)
Nov-10-25 08:00AM 4DMT Reports Third Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones link (GlobeNewswire)
Nov-06-25 04:05PM 4DMT to Participate in Jefferies 2025 London Healthcare Conference link (GlobeNewswire)
Nov-06-25 06:23AM 4DMT Announces Pricing of $100 Million Offering of Common Stock and Pre-Funded Warrants link (GlobeNewswire)
Nov-06-25 06:00AM 4DMT Announces Positive Long-Term Data from Phase 1/2 PRISM Clinical Trial in Wet AMD Supporting 4D-150's Potential as a Backbone Therapy with Consistent and Durable Benefit over Multiple Years link (GlobeNewswire)
Oct-30-25 11:02PM 4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific link (GlobeNewswire)
Oct-26-25 06:05AM 4D Molecular Therapeutics Secures Up to $11M More from CF Foundation to Accelerate 4D-710 Development link (Insider Monkey)
Oct-17-25 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Oct-17-25 09:55AM Wall Street Analysts See a 208.52% Upside in 4D Molecular Therapeutics (FDMT): Can the Stock Really Move This High? link (Zacks)
Oct-14-25 08:00AM 4DMT to Participate in Chardan's 9th Annual Genetic Medicines Conference link (GlobeNewswire)
Oct-13-25 08:00AM 4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation link (GlobeNewswire)
Sep-12-25 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Sep-11-25 12:45PM SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag link (Zacks)
Sep-05-25 03:12AM Jim Cramer on 4D Molecular Therapeutics: "This is a Pure Spec" link (Insider Monkey)
Sep-02-25 08:20PM Lightning Round: Now is time to take a little off the table with Applovin, says Jim Cramer link (CNBC TV)
Sep-02-25 08:00AM 4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness link (GlobeNewswire)
Aug-25-25 08:00AM 4DMT to Participate in Upcoming Investor Conferences link (GlobeNewswire)
Aug-15-25 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Aug-11-25 06:55PM 4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Misses Revenue Estimates link (Zacks)
Aug-11-25 08:00AM 4DMT Reports Second Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones link (GlobeNewswire)
Aug-06-25 08:00AM 4DMT to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference link (GlobeNewswire)
Jul-31-25 04:05PM 4DMT Presents Positive 60-Week Results from 4D-150 SPECTRA Clinical Trial in DME and Regulatory Update link (GlobeNewswire)
Jul-28-25 07:21AM AAV for the Hereditary Retinal Diseases Market Competitive Landscape Report 2025 | Novartis, MeiraGTx, 4D Molecular Therapeutics, and Beacon Therapeutics Lead the Charge in Innovative Therapies link (GlobeNewswire)
Jul-24-25 08:00AM 4DMT Announces Presentations at 43rd Annual Scientific Meeting of the American Society of Retina Specialists link (GlobeNewswire)
Jul-21-25 08:00AM BBOT Appoints Industry Veteran Uneek Mehra as Chief Financial Officer link (Business Wire)
Jul-11-25 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Jul-02-25 04:05PM 4DMT Announces Accelerated 4D-150 Phase 3 Development in Wet AMD and Streamlined Organization to Drive Late-Stage Execution link (GlobeNewswire)
May-28-25 08:00AM 4DMT to Participate in Upcoming Investor Conferences link (GlobeNewswire)
May-16-25 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
May-08-25 05:50PM 4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates link (Zacks)
May-08-25 04:05PM 4DMT Reports First Quarter 2025 Financial Results, Operational Highlights and Expected Upcoming Milestones link (GlobeNewswire)
May-05-25 08:00AM 4DMT to Participate in Upcoming Investor Conferences link (GlobeNewswire)
May-02-25 06:51AM FDA awards RMAT status to 4DMT diabetic macular oedema therapy link (Pharmaceutical Technology)
May-01-25 08:00AM 4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME link (GlobeNewswire)
Apr-11-25 04:05PM 4DMT Announces New Employment Inducement Grants link (GlobeNewswire)
Apr-01-25 11:50AM Biotech stocks slide as Marks resignation seen being negative for sector link (TipRanks)
Mar-27-25 08:00AM 4DMT to Participate in Upcoming Investor Conferences link (GlobeNewswire)
Mar-10-25 08:00AM 4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD link (GlobeNewswire)
Mar-04-25 08:05AM 4D Molecular price target lowered to $35 from $39 at RBC Capital link (TipRanks)
Feb-28-25 04:05PM 4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones link (GlobeNewswire)
Feb-19-25 08:00AM 4DMT to Participate in Upcoming Investor Conferences link (GlobeNewswire)
Feb-08-25 02:30PM 4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program link (GlobeNewswire)
Jan-29-25 08:00AM 4DMT Announces Corporate Webcast to Review Interim 52-week Results from the Phase 2b Cohort of PRISM in a Broad Wet AMD Population link (GlobeNewswire)
Jan-10-25 08:00AM 4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD and DME and 4D-710 in CF and Extends Cash Runway link (GlobeNewswire)
Jan-10-25 08:00AM 4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway link (GlobeNewswire)
Jan-10-25 08:00AM 4DMT Announces Positive Interim Data from 4D-150 SPECTRA Clinical Trial in DME and Alignment with FDA on Registrational Path link (GlobeNewswire)
Dec-16-24 08:00AM 4DMT Announces Landmark Publication of 4D-150 Preclinical Data for the Treatment of Neovascular Retinopathies in IOVS link (GlobeNewswire)
Nov-26-24 06:51AM 4D Molecular Therapeutics, Inc. (FDMT): An Oversold Healthcare Stock to Invest In Now link (Insider Monkey)
Nov-14-24 08:00AM 4DMT to Participate in Upcoming Investor Conferences and Ophthalmology Innovation Summit XIV link (GlobeNewswire)
Nov-13-24 05:20PM 4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates link (Zacks)
Nov-13-24 04:05PM 4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones link (GlobeNewswire)
Sep-25-24 09:35AM 4D Molecular Therapeutics (FDMT) Loses -26.01% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner link (Zacks)
Sep-23-24 08:00AM 4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference link (GlobeNewswire)
Sep-19-24 02:34PM 4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate link (Benzinga)
Sep-19-24 10:30AM 4D Molecular data bode well for eye gene therapy, but shares fall link (BioPharma Dive)
Sep-18-24 04:05PM 4DMT Highlights Robust and Durable Clinical Activity for 4D-150 and Design of 4FRONT Phase 3 Program at 4D-150 Wet AMD Development Day link (GlobeNewswire)
Sep-05-24 08:00AM 4DMT Announces Presentations at Upcoming Retina Conferences link (GlobeNewswire)
Sep-03-24 08:00AM 4DMT to Participate in the 2024 Cantor Global Healthcare Conference link (GlobeNewswire)
Aug-27-24 08:00AM 4DMT to Host 4D-150 Wet AMD Development Day on September 18, 2024 link (GlobeNewswire)
Aug-23-24 09:35AM 4D Molecular Therapeutics (FDMT) Loses -21.87% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner link (Zacks)
Aug-12-24 08:00AM 4DMT to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference link (GlobeNewswire)
Aug-08-24 05:55PM 4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Lags Revenue Estimates link (Zacks)
Aug-08-24 04:05PM 4DMT Reports Second Quarter 2024 Financial Results and Operational Highlights link (GlobeNewswire)
Aug-05-24 08:00AM 4DMT Advances Leadership in Large Market Ophthalmology with Senior Management Hires and Formation of Ophthalmology Advisory Board link (GlobeNewswire)
Jul-17-24 05:00AM 4DMT Announces Positive Phase 2 PRISM Interim Results for Intravitreal 4D-150 in a Broad Wet AMD Population Affirming Favorable Safety Profile and Robust Clinical Activity link (GlobeNewswire)
Jul-12-24 09:40AM 4D Molecular Therapeutics (FDMT) Moves 11.1% Higher: Will This Strength Last? link (Zacks)
Jul-08-24 05:52PM 4D Molecular Therapeutics, Inc. (FDMT): Why Are Analysts Bullish On This Shorted Stock? link (Insider Monkey)
Jul-08-24 12:30PM 10 Most Shorted Stocks That Are Loved by Analysts link (Insider Monkey)